|
|
|
| The Alliance for mRNA Medicines is hosting AMM ASCENT, its 1st Annual Meeting, on November 13-15 in Boston. The event brings together senior executives and decision-makers to advance mRNA research into vaccines and therapies for patients. Features include one-on-one partnering and networking opportunities, keynotes, and plenary/panel discussions among biotech, pharma, and academic leaders. Learn more and register here. |
|
|
|
|
By AR Welch, Editorial & Community Director, Advancing RNA | In the first of this two-part article, I’ll share a few of the commercial nuances informing what the path forward may look like for all of us in the ATMP financial sector. |
|
|
|
By Life Science Connect Editorial Staff | Rapid advancements in mRNA-based therapeutic development have underscored the role of raw material quality and supply chain management in ensuring their successful production. |
|
|
|
Tessera Therapeutics' CEO, Dr. Michael Severino, joins Host Erin Harris to discuss Gene Writing, the biotech's genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Severino discusses why delivery has always been a challenge for gene editing technologies and why Gene Writing is different when it comes to efficient delivery. |
|
|
|
|
| Advantages Of Cas9 mRNA For Gene Editing | Article | Vernal Biosciences | Discover why Cas9 mRNA is the preferred choice for precise gene editing, offering efficient delivery, transient expression, and flexible targeting. |
|
|
|
| LNP Formulation For mRNA Delivery | Article | Cytiva | Microfluidic mixing is one of the most effective means to formulate LNPs for its scalability and reproducibility. Explore LNP formulation, polishing, sterile filtration of mRNA-LNPs, and more. |
|
|
| An Introduction And Brief History Of mRNA-LNPs | Article | By Elizabeth Klavon, Helix Biotech | With adjustable components and increased stability during bloodstream circulation, LNPs are significantly advancing drug development and delivery, particularly for mRNA vaccines. |
|
|
|
| Transforming Drug Delivery | Brochure | Battelle | Learn how our team of scientists, engineers, and human-centered designers, as well as our world-class facilities, empower us to confidently guide your product toward a successful market launch. |
|
|
|
|
|
| It’s impossible to attend an event on the future of RNA therapeutics without hearing about the challenges we’re facing with targeted RNA-LNP delivery. In this final Advancing RNA Live discussion of 2024, we sit down with three LNP experts to parse out the current opportunities and unknowns facing the development of next-generation LNPs. Secure your spot today! Registration is free thanks to the support of Helix Biotech. |
|
|
.png){kind=logo}
